6123 Dec 14, 2003

Popular herbs and their active ingredients and proof of effectiveness as curative.

This page is www.lawyerdude.netfirms.com/herbs.html

Join my new group: http://groups.yahoo.com/group/drugs-flavorings-fragrances/

1. Regarding Cayenne pepper:

http://www.healthy.net/asp/templates/article.asp?PageType=Article&ID=866

2. A test was done on Essiac. It did not cure cancer. Essiac is supersition and stupidity I action. The herbs in the essiac formula are:

a. Burdock Root (Arcitum Lappa)

b. Turkish Rhubarb Root (Rheum Officinale)

c. Sheep Sorrel Herb (Rumex Acetosella)

d. Slippery Elm Bark (Ulmus Fulva )

e. And some fools say that the government suppressed the secret ingredient Comfrey. That is b.s. Cassie began with more ingredients and ended up with 4. She had no training in pharmacology - just local b.s. The active ingredient of comfrey is Symphytum officinale. Traditionally used to promote healing.

f. Two common additions are watercress and

g. Pau d'arco.

h. Yellow dock or

i. curly dock are sometimes used instead of sheep's sorrel.

In the mid 1920's, Rene Caisse was head nurse at the Sisters of Providence Hospital in a northern Ontario town. While on duty, she was bathing an elderly lady and noticed that one of her breasts had a lot of scar tissue on it. Upon questioning the lady, she learned that the women had advanced breast cancer 30 years earlier. The woman explained that she had met an old Indian medicine man from the Ojibway tribe who told her he could cure her cancer. She said that she had no money at that time, and didn't want to have an operation anyway, so she went to see the Indian. He showed her certain herbs growing in the area and told her to pick them and make a tea and drink it everyday.

1. She had no reoccurrence of cancer to that day, 30 years later.

Rene was very interested in what the women had told her and she wrote down the names of the herbs. A year later, her aunt had been diagnosed with stomach cancer with a liver involvement. She asked her Doctor, R.O. Fisher of Toronto, for permission to try the herbs on her under his observation. Her aunt lived 21 years after being given up on by the medical profession. Rene Caisse, never claimed that Essiac cured cancer, but her goal was to control it and alleviate the pain. From 1934 to 1942 she successfully treated thousands of terminally ill cancer patients in her clinic, many under the observation of a physician. Her own mother got cancer of the liver, and was immediately started on Essiac. She lived another 18 years.

Many doctors, surgeons, and scientists visited her cancer clinic, read case histories, and examined the patients. Many of them said they believed the Essiac acted upon the glands. It was able to bring back a balance to all the glands, and restore normal functioning.

Flor-Essence is an updated Essiac formula, with similar qualities as the original Essiac. Essiac is also known as Ojibwa, which is the name of the Indian tribe where the formula was originally developed.

What Essiac does! Essiac activates the body's own natural defenses without becoming habit-forming. Most patients experience less pain and overall improvement with the consistent use of Essiac and some patients continue to live for many years in good health. These four herbs, Burdock, Slippery Elm, Sheep Sorrel, and Turkish Rhubarb each have significant therapeutic effects on the body , and when they are combined, there is a synergistic effect.

The name "essiac" is common vernacular for an herbal tea attributed to Rene Caisse, a Canadian nurse who named it "Essiac" from backward spelling of her last name. Herbs used to make the tea are Burdock root (Arctium lappa), Sheep sorrel (Rumex acetosella), Slippery Elm bark (Ulmus fulva) and Turkish rhubarb (Rheum palmatum) or Indian rhubarb (Rheum officianale).

Sometime prior to 1922, Rene Caisse was given the recipe by an English miner's wife who said it came from an old medicine man. The original formula had 8 herbs but Rene refined it to the 4 herbs and named it "Essiac". Treating terminal cancer patients with Essiac, she gained physician support and operated her own Bracebridge Cancer Clinic from 1935 to 1941. However, Rene Caisse finally had to close her Clinic after endless hassles with Canadian health laws and Health officials.

Rene Caisse kept her formula a secret most of her life, concerned that lay people would make it incorrectly or it would be commercially exploited. She even refused to reveal it to interested research centers in the US, like Memorial Sloan-Kettering Cancer Center and the Brusch Medical Clinic.

When she was 89 years old, Rene Caisse signed over her Essiac recipe to Resperin Corporation Limited of Toronto, Ontario on October 26, 1977, because Resperin promised to do clinical trials to prove Essiac could cure cancer. Rene died 14 months after she signed the Resperin Agreement.

Resperin clinical trials were poorly conducted and in 1982, Health Canada concluded there was no evidence to support claims that Essiac was an effective cancer treatment. However, Essiac could be obtained by physician request under Canadian Emergency Drug Release Program for many years.

The Essiac formula and trademark was purchased from Resperin Corporation by David Dobbie in 1995 and his Essiac® Products Inc. of New Brunswick became the manufacturer of Essiac®. The allied Essiac® International of Ontario owned by Terry Maloney was formed to market the Essiac®. Resperin Corporation dissolved itself in 1998 and the Resperin rights were sold (but not to Essiac®).

"From Resperin Corporation" was the Canadian Essiac® promotion used to connect their formula to Rene Caisse, letting people think Resperin Corporation still made the product (despite Resperin protests about that use of its name). Essiac® promotion in 2000 became "From Resperin Canada", which usurped Resperin rights of real "Resperin Canada" company in Canada who owned the rights.

More confusion, two Essiac® trademarks exist, an unrelated company owned by Dr. Pierre Gaulin

of Florida holds the legal Essiac® trademark in the US. He sells all of the Rene Caisse formulas.

More controversy, Dr. Charles Brusch started claiming (after Rene died) that she had revealed her formula to him during her brief time at Brusch Medical Center in 1959-1960 (contradicted by evidence in a recent Snow/Klein book). Dr. Brusch got together with Elaine Alexander (Canadian broadcaster enthusiastic about essiac) to have Flor-Essence, his 8 herb tea, manufactured by Flora Inc. in 1993 (and Linda Paulhus of MA claims Brusch gave her a version of his 8 herb formula in 1986).

A few people knew Rene's Essiac formula. Rene became disappointed with Resperin and gave the recipe to Gilbert Blondin. Her close friend and helper Mary McPherson knew it and continued making Essiac for Rene's patients after she died. Dr. Gary Glum's 1988 book "Calling of An Angel" about Rene Caisse had a $79.95 video offer revealing her Essiac formula (he got it from Pat Judson, Detroit patient of Rene's). After the recipe became public, the essiac bandwagon started rolling with dozens of essiac entrepreneurs claiming to have "genuine" essiac or an "improved version".

The recipe was confirmed as the "real thing" by Mary McPherson, who helped Rene write out the formula for Resperin, and generic essiac marketers on Prices page claim they use this recipe.

Many essiac users follow this path. They may try a commercial bottled essiac tea first, then they will try a dry blend that makes just one gallon and learn how to brew with their own stainless steel equipment and bottles. To be sure of recipe accuracy and herb quality, some start making their own essiac tea from scratch using herbs from established herb suppliers like Blessed Herbs or Frontier. Once you have the equipment, cost of making your own essiac tea can be $5.00 per gallon or less.

--------------------------------------------------------------------------------

About the difference between "Essiac" and "essiac", no difference is justified?

Essiac is perceived as a treatment by FTC, FDA, Canadian Breast Cancer Research Initiative, medical and herb journals, and books about Essiac. Alternative medicine research center CIMER

at the University of Texas views Essiac as a treatment, refers more to Flor-Essence than Essiac®. Anecdotal claims that Essiac cures cancer or AIDS are not supported by US or Canadian scientific clinical studies so Essiac has never been approved by the FDA. As a treatment Essiac is unproven, unsubstantiated claims are illegal, but as a dietary food supplement it is not a medical treatment.

Official perception of Essiac as a treatment is seen on ftc.gov/os/2000/04/millerattachmenta.htm

which the FTC wrote and ordered an errant essiac marketer to send to his customers in April 2000:

If you are interested in the scientific research that has been done on alternative cancer treatments including Essiac, you may want to read a report published by the U.S. Office of Technology Assessment. The report is called, "Unconventional Cancer Treatments," and was published in 1990. Chapter 4 deals with herbal treatments including Essiac. The report collected the available published studies on Essiac tea and other alternative cancer remedies.

http://216.239.57.104/search?q=cache:gGDovpap1U0J:www.european-patent-office.org/correct/02_2pdfdocs/1174124a.pdf+%22Symphytum+officinale%22+formula+%22active+ingredient%22&hl=en&ie=UTF-8 This is from the patent office.

http://www.european-patent-office.org/correct/02_2pdfdocs/1174124a.pdf same thing in pdf.

http://www.european-patent-office.org/correct/02_2pdfdocs/1174124a.pdf

employed. Specific examples include plant extracts, animal extracts, guanidine derivatives,

catecholamines, amino acids, vitamins, hormones and organic acids.

[0030] Examples of the plant extracts include those having corium firming effects Ginkgo biloba (gingko), Foeniculi

Fructus (fennel), kiwi, Morus bombycis (mulberry), Gentiana lutea (gentian), red algae, Arctium lappa (burdock), Salvia

officinalis (sage), Lentinus edodes (shiitake mushroom), Perilla frutescens (perilla), Filipendula Multijuga, Fucus vesiculosis

(bladderwrack, sea weed), peach kernel, Panax ginseng (carrot), Allium sativum (garlic), Poria cocos (poria),

Humulus lupulus (hops), Mutan Cortex (Moutan Bark), Pimpinella major, Lactuca sative (lettuce), Astragalus membranaceous

(astragalus) and Rosmarinus officinalis (rosemary); those having whitening effects such as Prunus amygdalus

(almond), Althea officinale (althea), aloe, Rosae Fructus (rose fruit, or Rosa multiflora), Scuttelaria baicalensis

(Huang qin), Puerariae Radix (Pueraria Root, or Pueraria lobata), Chamomillae Flos (German chamomile), Gardenia

EP 1 174 124 A9 (W1A1)

jasminoides (zhii zi, Gardeniae Fructus), Sophora flavescens Aiton (Sophorae Radix), chlorella, rice bran, Paeoniae

lactiflora (white peony), ziyu (Sanguisorba officinalis, burnet), Morus alba (sang bai pi, mulberry), Glycine max (soybean),

Camellia sinensis (tea), Carthami Flos (safflower), Aesculus hippocastanum (horse chestnut), Melissa officinalis

(lemon balm) and Coicis Semen (Coix lacryma-jobi var. ma-yuen); those having blood circulation accelerating effects

such as Angelica keisukei, Arnica montana (arnica), Foeniculum officinale (fennel), Isodon japonicus Hara (Isodonis

Herba), Daucus Carota (carrot), Oryza sativa (rice), Crataegus cuneata (Japanese howthorn), Acorus calamus (sweet

flag), Crataegus oxycantha (howthorn), Juniperus communis, Ligusticum wallichii (Chinese lovage), Swertiae Herba

(Swertia Herb), Thymus vulgaris (garden thyme), Citrus reticulata (Citrus unshiu), Capsicum tincture, Angelicae sinensis

(angelica), Aurantii Pericarpium (bitter orange peel), Ruscus aculeatus (butcher's bloom), Vitis vinifera (grape),

Tilia japonica (lime), Citrus junos and Rosa canina (rose hip); those having lipolysis accelerating effects, for example,

thistles such as Cephalonoplos segetnum (Bieb.) Kitam. and Cirsium japonicum DC (Japanese Patent Application

Laid-Open No. 08-301780 (= USP5698199)), caffeine, Cinnamomi Cortex (cinnamon bark) and Eriobotrya japonica

Lindl. (loquat); those having anti-inflammatory effects Gambir, Echinacea, Phellodendri Cortex (amur cork tree or Phellodendron

amurense), Hypericum perforatum (St. John's wort), Citrus sinensis (orange), Valeriana fauriei Briquet, Artemisia

capillaris Thunb., Cucumis sativus (cucumber), Geranii Herba (Geranium Herb), Lithospermum erythrorhizon

Sieb. et Zucc., Hedera helix, Achillea millefolium (yarrow), Ziziphus jujuba (Chinese dates), Calendula officinalis (pot

marigold), Houttuynia cordata (Houttuyniae Herba, Houttuynia Herba), Potentilla erecta, Petroselinum crispum (parsley),

Parietaria officinalis, Santalum album (sandalwood), Prunus persica (peach), Centaurea cyanus (cornflower),

Eucalyptus globulus (eucalyptus) and Lavandula angustifolia (lavender); those having hair-growth accelerating effects

such as Persea americana (avocado), Aloe vera (aloe), Nasturtium officinalis (watercress), Symphytum officinale

(comfrey), Asarum sieboldii (wild ginger), Xanthoxyum piperitum (Japan pepper), Rehmannia glutinosa (di huang),

Mentha piperita (peppermint), Syzygium aromaticum (clove), Tussilago farfara (coltsfoot) and Haematoxylum

campechianum (logwood); and those having anti-aging effects such as Oolong tea, Cinchona succirubra (peruvian

bark), Betula verrucosa (birch) and Glechoma hederacea (ground ivy); while examples of the animal extracts include

placenta extract having whitening effects, milk and royal jelly having blood circulation accelerating effects, honey having

anti-inflammatory effects and pearl protein having cell activating action (for example, as described in Fragrance Journal

23(8), 41 to 47(1995), Ibid 24(8), 62 to 67(1996)).

[0031] As the component (b), those exemplified above may be used either singly or in combination. It is preferably

added to a composition in an amount of 0.00001 to 30%, especially 0.0001 to 20%. When the active ingredient is a

plant or animal extract, the amount does not include the extracting solvent but its solid content. As the extract, commercially

available ones in the liquid form may be used as is.

[0032] The composition for percutaneous administration of the present invention can be prepared by adding the

active ingredient in a solution or dispersion obtained by dissolving or dispersing at least two polymers forming a surfacesegragated

film to a volatile solvent.

[0033] As the volatile solvent, those having a boiling point of 210̊C or less, preferably 40 to 110̊C are preferred.

Water and lower alcohols (having 1 to 3 carbon atoms) are more preferred, with water and ethanol being especially

preferred. The volatile solvent is preferably added to the composition in an amount of 30 to 98%, especially 50 to 95%.

[0034] When the composition for percutaneous administration of the present invention is applied to the skin, a film

is formed with the polymer having lower surface tension being surface-segregated on the air interface side.

[0035] The composition for percutaneous administration of the present invention is prepared in a conventional manner

by adding various optional components ordinarily employed for cosmetics, quasi-drugs or drugs within an extent

not impairing the advantage of the present invention.